| Carla Williams, MD | |
|
1906 Belleview Ave Se, Roanoke, VA 24014 | |
| (540) 981-7000 | |
| Not Available |
| Full Name | Carla Williams |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 10 Years |
| Location | 1906 Belleview Ave Se, Roanoke, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386980357 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101262287 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carilion New River Valley Medical Center | Christiansburg, VA | Hospital |
| Carilion Medical Center | Roanoke, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carilion Medical Center | 9830096585 | 758 |
News Archive
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options.
HP today announced that seven of the top 10 healthcare companies have chosen its imaging and printing solutions to drive both clinical and financial value.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
› Verified 6 days ago
| Entity Name | Carilion Rockbridge Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174636021 PECOS PAC ID: 4789658261 Enrollment ID: O20040820000838 |
News Archive
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options.
HP today announced that seven of the top 10 healthcare companies have chosen its imaging and printing solutions to drive both clinical and financial value.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
› Verified 6 days ago
| Entity Name | Carilion Giles Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194718304 PECOS PAC ID: 3678670221 Enrollment ID: O20070516000487 |
News Archive
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options.
HP today announced that seven of the top 10 healthcare companies have chosen its imaging and printing solutions to drive both clinical and financial value.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
› Verified 6 days ago
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1649423815 PECOS PAC ID: 9830096585 Enrollment ID: O20090320000373 |
News Archive
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options.
HP today announced that seven of the top 10 healthcare companies have chosen its imaging and printing solutions to drive both clinical and financial value.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carla Williams, MD 213 S Jefferson St Ste 1006, Roanoke, VA 24011-1713 Ph: () - | Carla Williams, MD 1906 Belleview Ave Se, Roanoke, VA 24014 Ph: (540) 981-7000 |
News Archive
Ontario is partnering with Baylis Medical Company, a leading supplier of cardiology and radiology products, to support an R&D expansion project at the company's Mississauga manufacturing plant.
In a landmark cancer study published online in Nature, researchers at NYU School of Medicine have unraveled a longstanding mystery about how pancreatic tumor cells feed themselves, opening up new therapeutic possibilities for a notoriously lethal disease with few treatment options.
HP today announced that seven of the top 10 healthcare companies have chosen its imaging and printing solutions to drive both clinical and financial value.
Merck, known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck's anti-PD-1 therapy, has been approved by the China National Drug Administration for the treatment of adult patients with unresectable or metastatic melanoma following failure of one prior line of therapy.
University of Adelaide researchers have identified a likely molecular pathway that causes a group of untreatable neurodegenerative diseases, including Huntington's disease and Lou Gehrig's disease.
› Verified 6 days ago
Taylor Scott Franz, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 | |
Christopher M Lothes, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1906 Belleview Ave, Roanoke, VA 24033 Phone: 540-981-7000 Fax: 540-981-9550 | |
Dr. Kathryn Marie Steele, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-266-6331 | |
Hayley Rose-inman, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1906 Belleview Ave Se, Roanoke, Roanoke, VA 24014 Phone: 540-981-7000 | |
Dr. Stephanie Lareau, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 Fax: 540-985-6920 | |
Dr. Carol A Bernier, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-853-0182 Fax: 540-981-9950 | |
Kevin E Broyles, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1906 Belleview Ave Se, Emergency Dept, Roanoke, VA 24014 Phone: 540-981-7000 Fax: 540-981-9550 |